Elevated Lipoprotein(a) Clinical Trials In Beltsville, MD
If you have high Lp(a) levels and are at risk for cardiovascular disease, you may be eligible to take part in this lipoprotein(a) clinical trial at Metropolitan Clinical Research.
Understanding The Role of Lp(a) in Heart Health
Lipoprotein(a), or Lp(a), is a type of cholesterol-carrying particle in the blood. When Lp(a) levels are elevated, they can contribute to plaque buildup and inflammation, increasing the risk of serious cardiovascular events such as heart attack, stroke, and other heart-related complications.

Because high Lp(a) can increase cardiovascular risk, while treatment options remain limited, researchers are exploring whether a potential treatment for elevated lipoprotein(a) can reduce the risk of a first major cardiovascular event in adults 50 years and older.
See If You May Qualify for an Lp(a) Research Study
Complete this short form to see if you may qualify for the study.
High Lipoprotein(a) Clinical Trial For Adults At Risk For First Major Cardiovascular Event
This elevated Lp(a) clinical trial in Beltsville, MD is evaluating whether an investigational treatment may help reduce the risk of a first major cardiovascular event in adults with elevated Lp(a) levels and cardiovascular risk.Â
The study may help researchers better understand whether lowering Lp(a) levels could offer a potential new approach to preventing serious cardiovascular events and improving long-term heart health.
Why Participate in the at Metropolitan Clinical Research?
At Metropolitan Clinical Research, we believe in a patient-first approach in everything we do. Our experienced research team is committed to conducting patient-centric cardiovascular clinical trials with a focus on safety, clear communication, and making every participant feel supported throughout their study journey.Â
- When you take part in our lipoprotein(a) clinical trials, you can expect:
- Experienced professionals dedicated to advancing cardiovascular research
- Close attention and monitoring throughout your participationÂ
- Clear guidance and communication at every stage
- Your safety and well-being remain a priority
- A supportive, comfortable, and respectful study experience
If you are considering a Prevent-HF study in Beltsville, MD, our team is available to answer your questions and help you understand what participation involves.
Why This Study Matters
Your heart health can be at risk even when you feel completely fine. This is because elevated Lp(a) often goes unnoticed, but it can contribute to plaque buildup and increase the chance of a serious cardiovascular event. Since there are limited treatment options specifically targeting elevated Lp(a), researchers are looking for potential new ways to help reduce this risk before a major event happens.
Â
By participating, you can help researchers explore a potential new approach to lowering cardiovascular risk and contribute to advancing medical research.Â
Eligibility Criteria
Take part in our clinical trial for elevated Lp(a) and help researchers explore potential new ways to protect heart health.
- Age Group
50 Years and older (Adult, Older Adult )
- Gender
Male & Female
- Study Status
Heart Failure
- Location
Beltsville, MD
Frequently Asked Questions
Answers to common questions about our clinical research.
What is this heart failure prevention study?Â
This clinical research study is evaluating an investigational combination treatment that may help reduce the risk of developing heart failure and cardiovascular death in adults with type 2 diabetes, cardiovascular disease, and high blood pressure.
Who may be eligible for this heart failure prevention clinical trial?
Adults aged 40 and older with type 2 diabetes, established cardiovascular disease, and high blood pressure may be eligible. The study team will review your health history to determine if you meet all eligibility requirements.Â
Where is the Prevent-HF study taking place?
The heart failure prevention clinical study is being conducted at Metropolitan Cardiovascular Research (MCR) in Beltsville, MD.Â
What happens if I participate in the study?
Participants will receive study-related care and regular health monitoring throughout the study. The research team will explain the study procedures, visits, and participation requirements before enrollment.
What are the potential benefits of participating in this study?
Participants will receive study-related care and regular monitoring throughout the study. They may also receive compensation for their time and travel, if applicable. By taking part, participants can contribute to cardiovascular research that may help researchers better understand study treatment aimed at reducing the risk of a heart failure event or cardiovascular death.
Interested in Participating? Â We're Here to Help
Our team at Metropolitan Clinical Research is available to answer your questions and guide you through the next steps. Contact us today to learn more about our clinical research studies.Â